Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
8.80
-0.13 (-1.46%)
At close: Jul 11, 2025, 4:00 PM
8.81
+0.01 (0.11%)
After-hours: Jul 11, 2025, 7:40 PM EDT
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 130 employees as of December 31, 2024. The number of employees decreased by 170 or -56.67% compared to the previous year.
Employees
130
Change (1Y)
-170
Growth (1Y)
-56.67%
Revenue / Employee
$1,902,269
Profits / Employee
$306,500
Market Cap
1.19B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AUPH News
- 5 days ago - The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity - Seeking Alpha
- 12 days ago - Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - Business Wire
- 13 days ago - Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025 - Business Wire
- 7 weeks ago - New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis - Business Wire
- 2 months ago - Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga
- 2 months ago - Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - Business Wire
- 2 months ago - Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - Business Wire